The Concordance of Recursive Partitioning Analysis (RPA) Class Stratification with Survival of Brain Metastases Patients in Mohammad Hoesin Hospital, Palembang, Indonesia
The concordance of RPA, Diansari et al
DOI:
https://doi.org/10.32539/bsm.v5i2.202Keywords:
Brain Metastases, Recursive Partitioning Analysis, SurvivalAbstract
A B S T R A C T
Introduction: Recursive Partitioning Analysis is one of prognostic scores, has been
validated to any different setting. Objective: To identify the concordance of Recursive
Partitioning Analysis stratification in survival with brain metastases patients.
Methods: Retrospective study was performed on brain metastases patients from
January 2017 until Desember 2019 based on medical record. The follow up time
started from the first diagnosis of brain metastases to death or last follow up. The
Kaplan Meier was used to plot survival curves and the log-rank test was used to
analyse differences between groups Results: Mean overall survival time was 4,67
months with 1,14 months for median survival for all patients. According to scoring,
mostly (80,8%) patients were in group 3. The median survival time was 7 months
and 2 months for group 2 and 3. Conclusion: It has shown relatively congruity
survival in BM patients with stratification of Recursive Partitioning Analysis in our
institution.
Authors
- Yunni Diansari1*
- Selly Marisdina2
- Afriani2
- Dya Anggraeni3
- Hediaty Syafiera2
- 1Neurology Department, Faculty of Medicine, Universitas Sriwijaya, Mohammad Hoesin Hospital. Palembang. Indonesia
- 2neurology department, Universitas Sriwijaya, Mohammad Hoesin Hospital, Indonesia
- 3neurology department, Universitas Sriwijaya, Mohammad Hoesin Hospital, Namibia
Corresponding author Yunni Diansari — yunni.diansari@gmail.com
Article history
- Submitted
- Accepted
- Published
Downloads
Published
Issue
Section
License
Copyright and licensing
Copyright in each article remains with the author(s). Authors grant Bioscientia Medicina: Journal of Biomedicine and Translational Research a non-exclusive right of first publication and the right to identify itself as the original publisher. No exclusive transfer of copyright is required.
All articles are published under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0): https://creativecommons.org/licenses/by-nc-sa/4.0/. Users may copy, redistribute, remix, transform, and build upon the material for non-commercial purposes, provided appropriate attribution is given, a link to the license is supplied, changes are indicated, and adaptations are distributed under the same license.
The license applies to the article's scholarly content unless a credit line states otherwise. Third-party material may be subject to separate rights. Authors retain patent, trademark, moral, and research-data rights. The copyright year follows the article's publication date.
